Introduction
Pemphigus vulgaris is caused by an autoimmune process in which the immune system mistakenly attacks proteins that hold skin and mucosal cells together. Instead of being triggered by a single external agent, the condition develops when specific biological mechanisms fail and the body begins producing antibodies against desmoglein 3 and often desmoglein 1, two adhesion proteins essential for keeping the outer layers of the skin and the lining of the mouth intact. The disease usually arises from a combination of immune dysregulation, genetic susceptibility, and, in some people, environmental or medical triggers that help initiate or accelerate the autoimmune response.
Understanding the cause of pemphigus vulgaris requires looking at how the immune system is normally controlled, what goes wrong in antibody production, and why the affected tissues separate so easily when attacked. The main explanations fall into several categories: the core autoimmune mechanism, inherited risk, triggering exposures, and the ways other conditions can contribute to immune activation.
Biological Mechanisms Behind the Condition
The fundamental biological mechanism in pemphigus vulgaris is the production of pathogenic autoantibodies, usually of the IgG class, directed against desmogleins. Desmogleins are part of the desmosomes, specialized structures that act like molecular rivets between neighboring epithelial cells. In the mouth, throat, and skin, these junctions are crucial because these tissues are exposed to constant mechanical stress. When desmoglein function is disrupted, cells lose their ability to remain tightly attached, a process called acantholysis.
In a healthy immune system, self-reactive lymphocytes are eliminated, silenced, or kept under control by immune tolerance mechanisms. In pemphigus vulgaris, that tolerance breaks down. B cells begin producing antibodies against the body’s own adhesion molecules, and helper T cells support this abnormal immune response. The antibodies bind to desmogleins on the surface of epithelial cells and interfere with cell-to-cell adhesion in several ways. They can block the adhesive function of the proteins directly, cause the internalization and degradation of desmogleins, and activate signaling pathways that weaken cell attachment. Complement activation and inflammatory mediators may further contribute, although the disease is not simply a matter of generic inflammation; it is a targeted attack on structural proteins.
The reason blisters and erosions form is mechanical rather than infectious. Once epithelial cells detach from each other, even minor friction can separate layers of tissue, creating fragile blister roofs that rupture quickly. The mouth is often affected early because the mucosa is thinner and constantly exposed to movement, which makes the consequences of desmoglein disruption especially apparent there.
Primary Causes of Pemphigus vulgaris
The strongest cause of pemphigus vulgaris is the autoimmune production of antibodies against desmoglein 3, with many patients also developing antibodies to desmoglein 1. This immune response is not normal antibody defense against a foreign target; it is a misdirected response that develops through loss of self-tolerance. For reasons that are not fully understood, certain B cells begin recognizing desmogleins as antigens. Once activated, these B cells proliferate and produce large amounts of autoantibody, often with help from autoreactive T cells that amplify the response.
These autoantibodies alter the function of epithelial adhesion proteins. Desmoglein 3 is especially important in mucosal tissues, while desmoglein 1 is more prominent in the superficial layers of the skin. This distribution helps explain why oral lesions are common and why skin involvement may appear later or vary in severity. The precise combination of antibodies can influence the pattern of disease because different tissues rely on these adhesion molecules to different degrees.
Genetic predisposition is another major cause in the sense that it creates the immune environment in which autoimmune disease becomes more likely. Certain HLA class II genes, particularly specific HLA-DR and HLA-DQ variants, are associated with pemphigus vulgaris. These genes influence how antigen fragments are presented to T cells. If the immune system presents desmoglein-derived peptides in a way that strongly activates autoreactive T cells, the likelihood of antibody production increases. Genetics does not directly cause the disease on its own, but it shapes the immune system’s threshold for breaking tolerance.
Some cases are associated with external triggers that may initiate or reveal the autoimmune response. Medications are among the best-known examples. Certain drugs can induce a pemphigus-like syndrome or trigger true pemphigus vulgaris in susceptible individuals. The mechanism may involve alteration of immune regulation, structural changes in skin proteins that make them appear foreign, or enhanced B-cell activation. In some cases, the trigger is temporally linked to onset, suggesting that the drug helped expose or amplify a preexisting autoimmune tendency.
Contributing Risk Factors
Several factors can increase the likelihood of pemphigus vulgaris without being sufficient to cause it by themselves. One of the most important is family or inherited susceptibility. People with certain immune-related gene variants may have a greater tendency to generate autoantibodies when exposed to environmental or physiologic stressors. This does not mean the disease is directly inherited in a simple pattern, but rather that the regulatory systems controlling immune tolerance are less resilient.
Environmental exposures may also contribute. Some studies have linked the disease to exposure to pesticides, industrial chemicals, ultraviolet radiation, or other agents that can alter immune signaling or tissue integrity. These exposures may increase oxidative stress or cause subtle damage to epithelial cells, which can make self-antigens more visible to the immune system. In susceptible people, repeated immune stimulation may make it easier for autoreactive lymphocytes to expand.
Infections may act as nonspecific immune triggers. Viral or bacterial infections can stimulate cytokines, activate antigen-presenting cells, and increase general immune activity. This heightened state can lower the threshold for autoimmunity. In some theories, infections may also promote molecular mimicry, where microbial proteins resemble parts of self-proteins closely enough to confuse the immune system. While this is not proven as a universal cause, it is a plausible way that infection could contribute to disease onset in certain individuals.
Hormonal influences may affect immune reactivity as well. Autoimmune diseases often change in relation to sex hormones, and pemphigus vulgaris is more common in adults than in children. Estrogen and other hormonal signals can modify B-cell activity, T-cell regulation, and inflammatory responses. These effects do not create the disease independently, but they may alter how likely an immune response is to become self-directed.
Lifestyle factors are less direct but still relevant. Chronic stress, smoking, and poor overall health may affect immune balance and increase inflammatory signaling. For example, stress hormones can alter immune regulation, while smoking has been associated with changes in immune function and tissue repair. These influences are usually modest compared with the central autoimmune mechanism, but they can contribute to an immune environment in which disease becomes more likely or more active.
How Multiple Factors May Interact
Pemphigus vulgaris is best understood as a multi-factor disease. A person may inherit a genetic profile that makes immune tolerance less stable, then encounter a trigger such as a medication, infection, or environmental exposure that activates the immune system. If antigen-presenting cells display desmoglein-related peptides to susceptible T cells, those T cells can stimulate B cells to produce pathogenic antibodies. Once this cycle begins, the immune response may become self-sustaining.
These interactions matter because the immune system does not operate as isolated parts. B cells, T cells, cytokines, and tissue cells all influence one another. For instance, inflammatory signaling can increase antigen presentation, making self-proteins easier for the immune system to recognize. Tissue stress can expose or modify adhesion molecules, and that altered presentation can intensify the autoimmune response. The disease therefore emerges from a cascade rather than from a single lesion in one pathway.
In many cases, the body may tolerate autoantibodies at low levels for some time before clinical disease appears. Only when antibody concentration, immune activation, and tissue vulnerability reach a certain threshold do the adhesion defects become severe enough to produce blistering. This helps explain why onset can seem sudden even though the underlying autoimmune process may have been developing silently for months or years.
Variations in Causes Between Individuals
The causes of pemphigus vulgaris differ from person to person because immune susceptibility is not uniform. Some individuals have strong HLA associations that make them more likely to present desmoglein fragments to autoreactive T cells, while others may have different immune regulatory traits that influence how strongly they respond to triggers. Genetic background also affects how antibodies are shaped and which tissues become targeted most prominently.
Age can influence both immune behavior and tissue vulnerability. Pemphigus vulgaris most often appears in middle-aged or older adults, an age range in which immune regulation may become less robust and cumulative environmental exposures have had more time to act. Changes in thymic function, immune surveillance, and tissue repair may contribute to the later onset.
General health status is also important. People with other autoimmune tendencies, chronic inflammatory states, or immune dysregulation may be more likely to lose tolerance to self-antigens. Their immune systems may already be biased toward activation, making it easier for pemphigus-specific autoimmunity to develop. Likewise, differences in medication exposure, infection history, and occupational or geographic exposures can change the risk profile from one person to another.
Environmental exposure patterns can help explain geographic and familial clustering. If a person lives in an area with specific chemical exposures or repeated sun exposure, or has repeated infections that stimulate the immune system, those circumstances may interact with genetic predisposition in ways that another person never experiences. This is why the same disease can develop through different combinations of causes.
Conditions or Disorders That Can Lead to Pemphigus vulgaris
Several medical conditions can contribute to the development or unmasking of pemphigus vulgaris by disturbing immune regulation. Other autoimmune diseases are especially relevant because they indicate a tendency toward loss of self-tolerance. In such individuals, the immune system may already be primed to recognize self-antigens, making a second autoimmune disease more likely to appear.
Some malignancies, particularly those affecting the immune system, can alter immune surveillance and antibody production. When immune cell behavior becomes abnormal, autoreactive clones may escape control. Although pemphigus vulgaris is not classically a paraneoplastic disease in most patients, immune disturbances associated with cancer can sometimes contribute to autoantibody formation.
In addition, disorders that affect immune regulation, such as chronic immunologic activation or immunodeficiency with compensatory immune dysregulation, may influence disease onset. When the balance between immune activation and suppression is altered, the body may respond in an inappropriate or exaggerated way to self-proteins. This can allow pathogenic B-cell clones to persist and expand.
Some drug exposures can also trigger a pemphigus-like disorder or precipitate true pemphigus vulgaris in a predisposed person. The physiological relationship here is often a disruption of immune tolerance or a change in protein structure that makes desmogleins more immunogenic. In these situations, the underlying process still centers on autoantibody formation, but the initiating event may be a medication or another systemic illness that destabilizes immune control.
Conclusion
Pemphigus vulgaris develops because the immune system loses tolerance to desmoglein proteins and produces autoantibodies that break the connections holding epithelial cells together. The immediate biological cause is autoimmune attack on desmosomal adhesion molecules, which leads to acantholysis and fragile blister formation. Beneath that core mechanism are the factors that make the immune system misfire in the first place: genetic susceptibility, HLA-associated antigen presentation, environmental or medication triggers, infections, hormonal influences, and broader immune dysregulation.
The condition rarely has a single explanation. In one person, a genetic background may be the main risk, while in another, a drug exposure or another autoimmune disorder may help initiate the process. What unites these different pathways is a common endpoint: the body begins treating its own epithelial adhesion proteins as targets. Understanding these mechanisms clarifies why pemphigus vulgaris develops, why it can vary so much between individuals, and why the disease reflects a precise failure of immune self-recognition rather than a simple skin disorder.